Beaute by Novamed Healthcare Private Limited

Beaute by

Drug Labeling and Warnings

Beaute by is a Otc medication manufactured, distributed, or labeled by Novamed Healthcare Private Limited. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

BEAUTE- kojic acid cream 
Novamed Healthcare Private Limited

----------

Dosage and Administration

Use on cleaned face and neck for etter results

Avoid contact with eyes

If irritation develops, consult your dermatologist

Indications and Usage

Uses:

• Reduces Melanin
• Protects against UVA/UVB
• Prevents signs of ageing
• Controls Oil and Acne

Inactive Ingredients

• Sodium Benzoate
• Glycerine
• Cetostearyl Alcohol
• Titanium Dioxide
• Stearic Acid
• Water

Active Ingredients

Kojic Acid Dipalmitate

Xylitylglucoside

Allantoin

Dimethicone

EDTA

Cetyl Alcohol

Diethylene glycol distearate

Caprylic/ Capric Triglyceride

Triethanolamide

Sodium acrylyoldimethyl taurate copolymer

Cyclomethicone

Purpose

Ingredient Purpose

Kojic Acid Dipalmitate Skin Lighteneing agent

Xylitylglucoside Moisturizing + reconstructing/ healing agent

Allantoin Moisturizing + reconstructing/ healing agent

Dimethicone Surfactant / antiforming agent

EDTA Chelating agent

Cetyl Alcohol Emollient+thickner+ emulsifier

Diethylene glycol distearate Opacifying +Pearlising agent

Caprylic/ Capric Triglyceride Emollient

Triethanolamide Buffering agent

Sodium acrylyoldimethyl taurate copolymer Geling / Thickening agent

Cyclomethicone Surfactant / antiforming agent

Keep out of the reach of children

Keep out of the reach of children

Warnings

• For external use only
• Do not use on damaged or broken skin
• When using this product keep out of eyes. Rinse with water to remove.
• Stop use and ask a doctor if rash occurs
• Keep out of reach of children.If swallowed, get medical help or contacta Poison Control Center right away.

BEAUTE 
kojic acid cream

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 84859-114
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
KOJIC DIPALMITATE (UNII: 13N249RWTM) (KOJIC DIPALMITATE - UNII:13N249RWTM)	KOJIC DIPALMITATE	0.6 g  in 30 g
CYCLOMETHICONE (UNII: NMQ347994Z) (CYCLOMETHICONE - UNII:NMQ347994Z)	CYCLOMETHICONE	0.6 g  in 30 g
ALLANTOIN (UNII: 344S277G0Z) (ALLANTOIN - UNII:344S277G0Z)	ALLANTOIN	0.09 g  in 30 g
ACRYLAMIDE/SODIUM ACRYLOYLDIMETHYLTAURATE COPOLYMER (120000 MPA.S AT 1%) (UNII: 5F4963KLHS) (ACRYLAMIDE/SODIUM ACRYLOYLDIMETHYLTAURATE COPOLYMER (120000 MPA.S AT 1%) - UNII:5F4963KLHS)	ACRYLAMIDE/SODIUM ACRYLOYLDIMETHYLTAURATE COPOLYMER (120000 MPA.S AT 1%)	0.24 g  in 30 g
DIMETHICONE (UNII: 92RU3N3Y1O) (DIMETHICONE - UNII:92RU3N3Y1O)	DIMETHICONE	0.6 g  in 30 g
XYLITYLGLUCOSIDE (UNII: O0IEZ166FB) (XYLITYLGLUCOSIDE - UNII:O0IEZ166FB)	XYLITYLGLUCOSIDE	0.3 g  in 30 g
TRIETHANOLAMINE (UNII: 9O3K93S3TK) (TRIETHANOLAMINE - UNII:9O3K93S3TK)	TRIETHANOLAMINE	0.3 g  in 30 g
CAPRYLIC/CAPRIC TRIGLYCERIDE (UNII: C9H2L21V7U) (CAPRYLIC/CAPRIC TRIGLYCERIDE - UNII:C9H2L21V7U)	CAPRYLIC/CAPRIC TRIGLYCERIDE	0.75 g  in 30 g
DIETHYLENE GLYCOL DISTEARATE (UNII: 617Q4OD69O) (DIETHYLENE GLYCOL DISTEARATE - UNII:617Q4OD69O)	DIETHYLENE GLYCOL DISTEARATE	0.6 g  in 30 g
CETYL ALCOHOL (UNII: 936JST6JCN) (CETYL ALCOHOL - UNII:936JST6JCN)	CETYL ALCOHOL	0.3 g  in 30 g
EDTA (UNII: 9G34HU7RV0) (EDTA - UNII:9G34HU7RV0)	EDTA	0.03 g  in 30 g

Inactive Ingredients
Ingredient Name	Strength
CETOSTEARYL ALCOHOL (UNII: 2DMT128M1S)	0.45 g  in 30 g
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)	0.21 g  in 30 g
WATER (UNII: 059QF0KO0R)	19.647 mL  in 30 g
GLYCERIN (UNII: PDC6A3C0OX)	2.4 g  in 30 g
STEARIC ACID (UNII: 4ELV7Z65AP)	2.4 g  in 30 g
SODIUM BENZOATE (UNII: OJ245FE5EU)	0.09 g  in 30 g

Product Characteristics
Color	white	Score
Shape		Size
Flavor		Imprint Code
Contains

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 84859-114-01	1 in 1 BOX	01/28/2025	04/24/2025
1	NDC: 84859-114-30	30 g in 1 TUBE; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M016	01/28/2025	04/24/2025

Labeler - Novamed Healthcare Private Limited (645814547)

Registrant - Novamed Healthcare Private Limited (645814547)

Establishment
Name	Address	ID/FEI	Business Operations
Novamed Healthcare Private Limited		645814547	pack(84859-114) , manufacture(84859-114) , label(84859-114)

Revised: 5/2025

Document Id: 3528d270-5a3a-b651-e063-6394a90a416f

34390-5

Set id: 2cbf7ee9-d014-d08b-e063-6394a90a1cc5

Version: 2

Effective Time: 20250515